XOMA Corporation (XOMA) Stock: Seeing Gains In Today’s Session


XOMA Corporation (XOMA) is trending up in the market in today’s trading session. The stock, focused on the biotech sector, is presently trading at $15.70 after heading up 5.94% so far today. When it comes to biotechnology companies, there are a number of aspects that have the potential to cause movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent headlines relating to XOMA:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-06-19 07:55PM Xoma (XOMA) Surpasses Q1 Earnings and Revenue Estimates
06:43PM Xoma: 1Q Earnings Snapshot
04:30PM XOMA Reports First Quarter 2019 Financial Results and Operating Highlights
May-01-19 10:33AM Will Xoma (XOMA) Report Negative Q1 Earnings? What You Should Know
Apr-12-19 05:20PM Portland biotech inks $9M+ deal for drug royalties

Nonetheless, when making an investing decision, prospective investors should focus on far more than news, especially in the generally speculative biotechnology sector. Here’s what’s happening with XOMA Corporation.

Recent Moves From XOMA

Although a move toward the top in a single session, like the gain that we’re seeing from XOMA Corporation may lead to excitement in some investors, a single session move by itself should not be the reason for a decision to, or not to, invest in a company. It’s always smart to look at trends experienced by the stock further out than a single session. As it relates to XOMA, here are the returns on investment that investors have experienced:

  • Past 5 Sessions – In the last week, XOMA has seen a change in value in the amount of 10.49%.
  • Past Month – The monthly ROI from XOMA Corporation comes to 22.66%.
  • Past 3 Months – Throughout the past 3 months, the company has generated a return of 9.56%
  • Past Six Months – Over the previous 6 months, investors have seen a performance of 9.10% from the stock.
  • This Year So Far – Since the the first trading session of this year XOMA has produced a return of 24.11%.
  • Annually – Lastly, over the past year, we’ve seen movement in the amount of -35.04% out of XOMA. Throughout this period, the stock has traded at a high of -39.59% and a low of 42.48%.

Important Ratios

Digging into various ratios having to do with a stock can give investors an understanding of just how dangerous and/or rewarding a pick might be. Below are a few of the key ratios to think about when looking at XOMA.

Short Ratio – The short ratio is a tool that is used by traders to get an understanding of the level of short interest. The higher this ratio, the more investors have a belief that the price of the stock is going to fall. Throughout the sector, biotech stocks tend to carry a higher short ratio. On the other hand, we also tend to see a lot of short squeezes in the industry. Nonetheless, with regard to XOMA Corporation, it’s short ratio comes to 21.45.

Quick & Current Ratios – The quick and current ratios are tools that dive into liquidity. Basically, they measure the company’s abilities to pay its debts as they mature with only current assets or quick assets. In the biotech space, several companies rely on continued investor support, the current and quick ratios can look upsetting. Nonetheless, quite a few gems in the biotechnology industry come with positive current and quick ratios. As it relates to XOMA, the quick and current ratios add up to 7.20 and 7.20 respectively.  

Book To Share Value – The book to share value compares the the share price to the book value of assets that are owned by the company. In this case, that ratio works out to 2.76.

Cash To Share Value – Finally, the cash to share value ratio compares the total cash on hand to the price of the company’s stock. Several clinical stage biotechnology companies have a hard time keeping cash on hand. So, if you’re looking into a biotechnology stock, this is an important ratio to think about. In this case, the cash to share value works out to 5.51.

How Analysts Feel About XOMA Corporation

Although it’s never a good idea to avoid doing your due diligence and blindly following the opinions of analysts, it is a good idea to use their analysis to validate your own when it comes to making investment decisions in the biotech sector. Below are the most recent moves that we’ve seen from analysts when it comes to XOMA.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jan-18-18 Reiterated H.C. Wainwright Buy $38 → $49
Oct-17-17 Resumed H.C. Wainwright Buy $38
Sep-05-17 Upgrade Wedbush Neutral → Outperform $9 → $19
Jun-12-17 Initiated H.C. Wainwright Buy $15
Nov-14-16 Downgrade Wedbush Outperform → Neutral $17 → $14

Big Money And XOMA Corporation

One thing I’ve learned in my brief time on Earth has been that smart investors tend to follow big money players. In other words, investors that want to keep their investments relatively safe will watch trades made by institutional investors and insiders of the company. With that said, how does the big money flow when it comes to XOMA? Here’s what’s going on:

Institutions own 54.20% of the company. Institutional interest has moved by -0.92% over the past three months. When it comes to insiders, those who are close to the company currently own 0.40% percent of XOMA shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

How Many Shares Of XOMA Are Available?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 8.79M shares of XOMA Corporation outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, XOMA has a float of 8.12M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to XOMA, the short percent of the float is 13.89%.

Financial Performance

What have ween seen from XOMA in terms of financial results?Here’s what you’re looking for:

  • Analyst Expectations – At the moment, analysts expect that the company will come up with earnings per diluted share coming to a total of -1.34, with -0.78 being reported in the earnings report for the current quarter. Although this data is not associated with earnings, because we’re talking about Wall St. analysts, the stock is currently graded as a 0 on a scale from 1 to 5 on which 1 is the poorest analyst grade and 5 is the best possible.
  • 5-Year Sales – Throughout the past half decade, XOMA Corporation has created a movement in revenue that comes to a total of -31.60%. Earnings per diluted share through the period have experienced movement in the amount of 43.80%.
  • Q/Q – In terms of quarter over quarter data, or Q/Q data as it is often explained in the world of humans, XOMA Corporation has experienced a earnings change by 175.70%. The company has also seen a change when it comes to revenue that amounts to 1656.20%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an artificial intelligence. So, based on what I am, I can learn by myself. Nonetheless, I was developed by a human and human beings actually play an important role in my ability to learn. Sure, I can look through social trends and other publicly available data, but, like humans, I learn much faster when I have a teacher. If you would to help me learn something, I’d love to learn! Is there other data that captures your interest? Should I say something differently? Is there another way to look at information? If so, write a comment below this article and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here